Bitcoin rallies to new ATHs alongside the launch of the first futures backed ETF. Long-term Holders are taking modest profits, however are slowing spending during the dip.
The latest issue of Music & Copyright is now available for subscribers to download. Here are some of the highlights. Recorded-music trade growth set to eclipse modest rise in revenue for music publishers With all the world’s major recorded-music markets and one or two other smaller ones having published midyear trade figures, Music & Copyright‘s … Continue reading New issue of Music & Copyright with Italy country report→
On 1 September 2021, Sony’s ‘Vita’ trade mark lost out in genuine use revocation proceedings in the EU General Court (see case T‑561/20). The trade mark Vita had been registered by Sony for a variety of class 9 items, including “data carriers containing programs” and “audio and/or image carriers (not of paper).” Vieta Audio applied...
Alpha Tau Medical Ltd. (“Alpha Tau”) is a medical technology start-up focused on the research, development, and commercialization of its Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) treatment for solid cancerous tumors. On October 8, 2021, Alpha Tau announced that it received FDA Breakthrough Device Designation for using Alpha DaRT to treat recurrent glioblastoma multiforme (GBM). GBM is an aggressive, often incurable form of cancer responsible for malignant brain tumors.
According to the FDA, the goal of its Breakthrough Devices Program is to “provide patients and health care providers with timely access to [] medical devices by speeding up their development, assessment, and review.”
“As GBM is such a terrible disease, it is critical that we find new solutions for these patients, and we are thrilled that receipt of the FDA’s Breakthrough Device Designation will allow us to expedite our clinical collaborations with leading cancer centers in the U.S. and across the world, and to bring new hope for GBM patients. I am very proud of our team and our collaborators who have worked hard to extend the use of Alpha DaRT to GBM and have already accomplished so many amazing things. This is fantastic news for Alpha Tau and fantastic news for so many GBM patients around the world.”
Alpha DaRT works by first inserting a “seed” into a cancerous tumor. The seed then releases high-energy alpha particles that destroy the tumor while sparing the healthy tissue around it.
This is the second FDA Breakthrough Device Designation Alpha Tau has received. In June 2021, Alpha Tau announced the FDA’s designation of Alpha DaRT for treating squamous cell carcinoma, a type of skin cancer.
In Metso Outotec Corporation v. the Registrar of Trade Marks, appeals were preferred before the Bombay High Court from orders passed by the Registrar of Trade Marks in respect of trademark applications for the word mark SISUPER and device mark SISUPER bearing application nos. 4433306 and 4435364 respectively (IR Nos. 1513304 and 1512932). After a perusal of the facts of the case, the Court set aside and quashed the decisions of the Senior Examiner of Trade Marks refusing the mark “SISUPER”.
Anthony Arundel, co-author of Harnessing public research for innovation in the 21st Century: An international assessment of knowledge transfer policies, discusses the main gaps in our understanding of how knowledge transfer works and key considerations for policymakers in crafting effective knowledge transfer policies for the future.
What has been the impact of the COVID-19 health crisis been on the innovation landscape? Sacha Wunsch-Vincent, Senior Economist and co-editor of the GII 2021 at WIPO discusses the report’s key findings.
A Simple, Post-Consumer Model for (Real) Education Education is an interactive experience. The wave of consumerization of education is arguably several decades old now. To my view, there are two prevailing themes of that consumerization: 1) the idea of student-customer who is therefore “always right” and deserves guarantees of certain outcomes like employability and ROI, […]
The social cost of carbon (SCC) is an extremely important tool for understanding our global climate change situation and determining the most cost-effective solutions....
A Microsoft-funded study by Carbon Plan, an independent non-profit that reviews and rates carbon credits, recently released a buyer’s guide with their assessment of...
